The ICR and Cancer Research UK join forces with leading science and technology company in new drug discovery alliance

The deal follows previous drug discovery collaborations and a more recent successful target validation collaboration between Merck and Cancer Research UK’s Cancer Therapeutics Unit at the ICR.
Institute of Cancer Research